Filing Details

Accession Number:
0001209191-23-004816
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-25 16:08:09
Reporting Period:
2023-01-23
Accepted Time:
2023-01-25 16:08:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1334365 Yuchun Lee C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-23 2,129 $72.14 4,004 No 4 M Direct
Common Stock Disposition 2023-01-23 2,129 $312.02 1,875 No 4 S Direct
Common Stock Acquisiton 2023-01-24 4,000 $72.14 5,875 No 4 M Direct
Common Stock Disposition 2023-01-24 2,511 $312.29 3,364 No 4 S Direct
Common Stock Disposition 2023-01-24 1,489 $313.36 1,875 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-01-23 2,129 $0.00 2,129 $72.14
Common Stock Stock Option (Right to Buy) Disposition 2023-01-24 4,000 $0.00 4,000 $72.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,429 2024-05-31 No 4 M Direct
9,429 2024-05-31 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
  2. Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  3. Open market sales reported on this line occurred at a weighted average price of $312.02 (range $312.00 to $312.17).
  4. Open market sales reported on this line occurred at a weighted average price of $312.29 (range $312.00 to $312.92).
  5. Open market sales reported on this line occurred at a weighted average price of $313.36 (range $313.00 to $313.73).
  6. Fully vested.